Overview

Detailed Summary

Curis Lifesciences Limited primarily manufactures pharmaceutical products, covering a diverse range of formulations including tablets, capsules, and ointments. Their core markets are Africa and Latin America, with a focus on contract manufacturing and direct exports.
The company has a strong export focus, with 63.78% of its turnover being international, and key markets including Nigeria and Kenya. Their strategic focus on exports supports higher profit margins.
Curis Lifesciences is expanding its partnerships and facilities, including a significant JV with Eurosun Pharmaceuticals for Nigerian market penetration, indicating strategic growth.
The company’s contract manufacturing model provides flexibility, incorporating both domestic and international clients and catering to brand-specific needs.
Curis’s recent financial performance shows robust growth in EBITDA margins, with a shift from lower-margin operations to higher-margin contract manufacturing for export markets.

Sector: Pharmaceuticals
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Market Cap: 75 Cr
Volatility: Low Risk
P/E Ratio: 9.1
Industry P/E: 28.1
PEG Ratio: 0.1
P/B Ratio: 2.0
52W High: 147.90
52W Low: 92.60

Sales CAGR

1Y: 38.16%
3Y: 27.43%
5Y: —
10Y: —

Profit CAGR

1Y: 25.46%
3Y: 131.45%
5Y: —
10Y: —

ROE

TTM: —
3Y: 57.08%
5Y: —
10Y: —

ROCE

TTM: —
3Y: 40.10%
5Y: —
10Y: —

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VAISHALI	6.51	85 Cr	-2.30	1.26	0.00	-0.57	1.54	-0.43
SOURCENTRL	127.00	81 Cr	29.40	3.42	0.00	12.56	15.10	6.85
CURIS	93.30	75 Cr	9.07	2.01	0.00	0.00	0.00	0.00
CONCORD	74.20	74 Cr	145.49	2.16	0.00	1.67	6.00	0.83
ACCPL	65.45	73 Cr	7.72	1.62	0.00	19.50	25.71	15.37
AMWILL	35.00	70 Cr	5.28	1.01	0.00	11.07	11.52	10.35
ONYX	33.00	60 Cr	9.97	1.08	0.00	1.95	4.14	1.16

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2024
Sales	9.12
Expenses	6.39
Operating Profit	2.73
OPM %	29.93
Other Income	0.00
Interest	0.25
Depreciation	0.17
Profit Before Tax	2.31
Tax %	48.05
Net Profit	1.20
EPS in Rs	—

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	24	35	36	49
Expenses	20	32	27	40
Operating Profit	3.58	3.25	8.43	9.54
OPM %	15.08	9.18	23.71	19.41
Other Income	0.02	0.34	0.31	0.51
Interest	1.62	1.33	0.85	1.11
Depreciation	0.75	0.73	0.68	0.67
Profit Before Tax	1.23	1.54	7.22	8.27
Tax %	59.86	20.43	25.81	26.17
Net Profit	0.49	1.23	5.36	6.11
EPS in Rs	—	—	—	—
Dividend Payout %	0.00	0.00	0.00	0.00

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.50	0.50	0.50	5.93
Reserves	-1.40	-0.18	5.18	10
Borrowings	18	16	17	16
Other Liabilities	11	13	11	11
Total Liabilities	27	30	34	43
Fixed Assets	12	12	12	11
CWIP	0.00	0.00	0.00	0.02
Investments	0.01	0.01	0.01	0.01
Other Assets	15	17	22	32
Total Assets	27	30	34	43

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity	4.95	3.35	0.28
Cash from Investing Activity	-0.37	-0.55	-0.06
Cash from Financing Activity	-4.58	-2.76	0.05
Net Cash Flow	-0.01	0.04	0.27

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2024	Jun 2025	Oct 2025	Nov 2025
Promoters	92.68%	92.68%	92.68%	68.03%
FIIs	0.00%	0.00%	0.00%	2.93%
DIIs	0.00%	7.32%	7.32%	10.94%
Public	7.32%	0.00%	0.00%	18.10%
Total Shareholders	27	35	36	542

Market Transactions

Unlock Premium Features

Analyst Target, Price, EPS and Revenue Projections

Upgrade

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Curis Lifesciences Ltd

Curis Lifesciences Ltd (CURIS) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Curis Lifesciences Limited primarily manufactures pharmaceutical products, covering a diverse range of formulations including tablets, capsules, and ointments. Their core markets are Africa and Latin America, with a focus on contract manufacturing and direct exports. The company has a strong export focus, with 63.78% of its turnover being international, and key markets including Nigeria and Kenya. Their strategic focus on exports supports higher profit margins. Curis Lifesciences is expanding its partnerships and facilities, including a significant JV with Eurosun Pharmaceuticals for Nigerian market penetration, indicating strategic growth. The company’s contract manufacturing model provides flexibility, incorporating both domestic and international clients and catering to brand-specific needs. Curis’s recent financial performance shows robust growth in EBITDA margins, with a shift from lower-margin operations to higher-margin contract manufacturing for export markets.

Over the past 52 weeks, Curis Lifesciences Ltd has traded between a low of ₹NaN and a high of ₹NaN. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Curis Lifesciences Ltd has a market capitalization of approximately 75.43. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Curis Lifesciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 9.07 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 75.43 Cr, Curis Lifesciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Curis Lifesciences Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Curis Lifesciences Ltd is 9.07. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Curis Lifesciences Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Peers

Price Chart Comparison

Financial Statements

AI Powered Summary

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

Standalone Profit Loss (in ₹ Crores)

Standalone Balance Sheet (in ₹ Crores)

Standalone Cash Flows (in ₹ Crores)

Shareholdings

Shareholding History

Market Transactions

Unlock Premium Features

Upgrade

Projection

Documents

Actions

Announcements

AI Mode

Ask AI

Frequently Asked Questions about Curis Lifesciences Ltd

What is Curis Lifesciences Ltd share price today?

What does Curis Lifesciences Ltd do?

What is the 52-week high and low of Curis Lifesciences Ltd?

What is the market capitalization of Curis Lifesciences Ltd?

Should I consider investing in Curis Lifesciences Ltd stock?

Is Curis Lifesciences Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Curis Lifesciences Ltd belong to and why does it matter?

What is the PE ratio of Curis Lifesciences Ltd?

Utility

Company

Technicals

Forecasts

Projection

Frequently Asked Questions about Curis Lifesciences Ltd

What is Curis Lifesciences Ltd share price today?

What does Curis Lifesciences Ltd do?

What is the 52-week high and low of Curis Lifesciences Ltd?

What is the market capitalization of Curis Lifesciences Ltd?

Should I consider investing in Curis Lifesciences Ltd stock?

Is Curis Lifesciences Ltd a large-cap, mid-cap, or small-cap stock?

Which sector does Curis Lifesciences Ltd belong to and why does it matter?

What is the PE ratio of Curis Lifesciences Ltd?

Announcements

Oscillators

Neutral

Overall

Neutral

Moving Averages

Neutral

Overall

Neutral

Peers

Price Chart Comparison

Overview

Financial Ratios

Investment Checklist